Philips to acquire BioTelemetry, Inc. for USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion) Acquisition is a strong fit with Philips’ strategy to transform the delivery of healthcare: combination of Philips’ leading patient monitoring position in the hospital with BioTelemetry’s leading cardiac diagnostics and monitoring position outside the hospital With 2019 sales of USD 439 million, BioTelemetry annually … Continued
Geneva Health Solutions a leading solutions provider of technology-enabled services in the implantable cardiac device space, and a BioTelemetry, Inc. company (NASDAQ:BEAT), released its cardiac device data findings at the 40th Annual (2019) Heart Rhythm Society (HRS) conference. Geneva’s proprietary cloud-based platform aggregates data from leading cardiac device manufacturer systems and provides physicians and their … Continued
Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, has formalized its internal training systems by launching Geneva University, a business unit within GHS. Geneva University will be focused on the continuous improvement of all clinical and administrative processes. “Implantable cardiac device remote monitoring requires distinct data … Continued